Emmaus Life Sciences, Inc Alternatives & Competitors
12 companies similar to Emmaus Life Sciences, Inc — Improving the lives of people with rare disease.
Companies similar to Emmaus Life Sciences, Inc
Biodexa Pharmaceuticals PLC
Advancing Medicines for a Brighter Future
Cardiff, United Kingdom
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Solid Biosciences
#TogetherWeAreSolid
Boston, United States
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Rival Readout
Competing with Emmaus Life Sciences, Inc? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Gain Therapeutics
Unfolding the next generation of allosteric small molecule therapies to meet patient needs...
Bethesda, United States
-Corp.-logo.jpg "SyneuRx International (Taiwan) Corp."){kind=logo}
SyneuRx International (Taiwan) Corp.
Developing new classes of drugs for COVID-19 and multiple major central nervous system dis...
Taiwan
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
Quercis Pharma
For a Healthier World
Zug, Switzerland
RiboNova, Inc.
Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset...
Wynnewood, United States
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
South San Francisco, Unit...
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
San Diego, United States
About Emmaus Life Sciences, Inc
Emmaus Life Sciences, Inc is at the forefront of the biopharmaceutical industry, specializing in the discovery, development, and commercialization of treatments for rare and orphan diseases. The company is particularly focused on addressing Sickle Cell Disease, a challenging genetic disorder. Founded in 2000 and headqu...
Development and commercialization of pharmaceutical treatments, Telehealth for prescription management and patient support, Conducting clinical trials and medical research
Patients with sickle cell disease, Patients with diverticulosis, Healthcare professionals and providers, Global health regulatory bodies
Biopharmaceuticals, Rare Diseases, Orphan Diseases, Sickle Cell Disease, L-glutamine Treatment, Phase 3 Clinical Trials, Sickle Cell Anemia, Sickle ß0-thalassemia, Short Bowel Syndrome, FDA Orphan Drug Designation, Fast Track Designation, Pharmaceutical Grade Treatments, Genetic Disorders
B2C, B2B, D2C
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Emmaus Life Sciences, Inc: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Emmaus Life Sciences, Inc on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
